Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss. It also provides anti-biotic, anti-fungal, anti-viral, anti-ulcerant, anti-epliepsy products; external agents; anti-cancer drugs; amino-acid nutrient transfusion agents; and cosmetics. Aprogen Biologics Inc. was founded in 1960 and is headquartered in Seongnam-si, South Korea.
Stock data | 2024 | Change |
---|---|---|
Price | $0.7879902746150592 | N/A |
Market Cap | $524.60M | N/A |
Shares Outstanding | 665.75M | N/A |
Employees | 363.00 | N/A |